Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marian Sorin Paveliu"'
Autor:
Szczepan Jakubowski, Pawel Kawalec, Przemyslaw Holko, Iwona Kowalska-Bobko, Maria Kamusheva, Guenka Petrova, Pero Draganić, Leos Fuksa, Agnes Männik, Fanni Ispán, Vitalis Briedis, Ioana Bianchi, Marian Sorin Paveliu, Tomas Tesar
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objectives: The aim of this study was to characterize the reimbursement policy for orphan drugs (ODs) in Central and Eastern European (CEE) countries in relation to the availability and impact of clinical evidence, health technology assessment (HTA)
Externí odkaz:
https://doaj.org/article/13de524ced3b41b7bff0b3ba11c5c87c
Autor:
Elena Olariu, Raluca Caplescu, Luke Vale, Ileana Gabriela Niculescu-Aron, Yemi Oluboyede, Marian Sorin Paveliu
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background The majority of patient reported outcome measures (PROMs) don’t have population norms in Romania. This is the case with the EQ-5D as well. Therefore, we aimed to estimate population norms for the Romanian versions of the EQ-5D-5
Externí odkaz:
https://doaj.org/article/2ee59685266f4e5f9191614faed59c37
Autor:
Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Christoph Sowada, Guenka Petrova, Manoela Manova, Alexandra Savova, Pero Draganić, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar, Marian Sorin Paveliu
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-13 (2020)
Abstract Background The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive d
Externí odkaz:
https://doaj.org/article/3a15a73178a843488cbbf82641d08803
Autor:
Elena Olariu, Marian Sorin Paveliu, Eugen Baican, Yemi Oluboyede, Ileana Gabriela Niculescu-Aron
Publikováno v:
BMJ Open, Vol 9, Iss 8 (2019)
IntroductionThe importance of health-related quality of life (HRQoL) is increasing and many healthcare authorities recommend the use of measures that account for both mortality and morbidity. This study will determine, for the first time in Romania,
Externí odkaz:
https://doaj.org/article/164b12eb050c453092c7982a8fbe80b7
Autor:
Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Marcin Czech, Guenka Petrova, Manoela Manova, Alexandra Savova, Pero Draganić, Lenka Vostalová, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar, Marian Sorin Paveliu
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
BackgroundReimbursement policies influence access of patients to orphan drugs in the European countries.ObjectivesTo provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making process in the
Externí odkaz:
https://doaj.org/article/0060948c11e742faa55b2b79d100a3a7
Autor:
Elena Olariu, Raluca Caplescu, Luke Vale, Ileana Gabriela Niculescu-Aron, Yemi Oluboyede, Marian Sorin Paveliu
Background The majority of patient reported outcome measures (PROMs) don’t have population norms in Romania. This is the case with the EQ-5D as well. Therefore, we aimed to estimate population norms for the Romanian versions of the EQ-5D-5L, EQ-5D-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f97c23472859d1c62b0d06229683543
https://doi.org/10.21203/rs.3.rs-2144821/v1
https://doi.org/10.21203/rs.3.rs-2144821/v1
Autor:
Ileana-Gabriela Niculescu-Aron, Yemi Oluboyede, Marian Sorin Paveliu, Raluca Caplescu, Elena Olariu, Simona Ernu, Luke Vale
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 18
Issue 14
International Journal of Environmental Research and Public Health, Vol 18, Iss 7415, p 7415 (2021)
Volume 18
Issue 14
International Journal of Environmental Research and Public Health, Vol 18, Iss 7415, p 7415 (2021)
Objective: To provide health-related quality of life (HRQoL) data to support health technology assessment (HTA) and reimbursement decisions in Romania, by developing a country-specific value set for the EQ-5D-3L questionnaire. Methods: We used the cT
Autor:
Elena Olariu, Wael Mohammed, Yemi Oluboyede, Raluca Caplescu, Ileana Gabriela Niculescu-Aron, Marian Sorin Paveliu, Luke Vale
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care.
Objective We aimed to develop an EQ-5D-5L value set for Romania. Methods In line with the EuroQoL standardized valuation protocol, computer-assisted interviews were conducted face-to-face in a representative sample in Romania (November 2018–Novembe
Autor:
Wojciech Trąbka, Guenka Petrova, Manoela Manova, Christoph Sowada, Pero Draganić, Agnes Männik, Alexandra Savova, Krzysztof Piotr Malinowski, Kristóf Márky, Marian Sorin Paveliu, Tomas Tesar, Paweł Kawalec, Juraj Slabý, Zinta Rugaja, Jolanta Gulbinovič
Publikováno v:
Orphanet journal of rare diseases, London : BioMed Central, 2020, vol. 15, no. 1, art. no. 277, p. [1-13]
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-13 (2020)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-13 (2020)
Background The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive descriptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e500972dee9ea52912420e7fe38731d0
https://www.bib.irb.hr/1223202
https://www.bib.irb.hr/1223202
Autor:
Luke Vale, Aureliano Paolo Finch, Yemi Oluboyede, Elena Olariu, Marian Sorin Paveliu, Raluca Caplescu, Ileana Gabriela Niculescu-Aron
Publikováno v:
Value in Health